X @Bloomberg
Bloombergยท2025-07-03 14:28Partnership & Licensing - AstraZeneca is in discussions for a partnership with Summit Therapeutics to license a lung-cancer drug [1] - The potential deal could involve AstraZeneca paying up to $15 billion over time [1]